Novozymes Retained Earnings (Accumulated Deficit) 2011-2023 | NVZMY
Novozymes retained earnings (accumulated deficit) from 2011 to 2023. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Novozymes retained earnings (accumulated deficit) for the quarter ending December 31, 2023 were $1.997B, a 7.98% increase year-over-year.
- Novozymes retained earnings (accumulated deficit) for 2023 were $1.997B, a 7.98% increase from 2022.
- Novozymes retained earnings (accumulated deficit) for 2022 were $1.85B, a INF% increase from 2021.
- Novozymes retained earnings (accumulated deficit) for 2021 were $0B, a 100% decline from 2020.
Novozymes Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023 |
$1,997 |
| 2022 |
$1,850 |
| 2021 |
$ |
| 2020 |
$1,725 |
| 2019 |
$1,620 |
| 2018 |
$1,733 |
| 2017 |
$1,650 |
| 2016 |
$1,558 |
| 2015 |
$1,547 |
| 2014 |
$1,820 |
| 2013 |
$1,793 |
| 2012 |
$1,464 |
| 2011 |
$1,759 |
| 2010 |
$1,444 |
Novozymes Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2023-12-31 |
$1,997 |
| 2023-09-30 |
$2,017 |
| 2023-06-30 |
$1,885 |
| 2023-03-31 |
$1,770 |
| 2022-12-31 |
$1,850 |
| 2022-09-30 |
$1,625 |
| 2022-06-30 |
$1,560 |
| 2022-03-31 |
$1,581 |
| 2021-12-31 |
|
| 2021-09-30 |
$1,786 |
| 2021-06-30 |
$1,744 |
| 2021-03-31 |
$1,714 |
| 2020-12-31 |
$1,725 |
| 2020-09-30 |
$1,664 |
| 2020-06-30 |
$1,527 |
| 2020-03-31 |
$1,494 |
| 2019-12-31 |
$1,620 |
| 2019-09-30 |
$1,555 |
| 2019-06-30 |
$1,577 |
| 2019-03-31 |
$1,562 |
| 2018-12-31 |
$1,733 |
| 2018-09-30 |
$1,651 |
| 2018-06-30 |
$1,645 |
| 2018-03-31 |
$1,651 |
| 2017-12-31 |
$1,650 |
| 2017-09-30 |
$1,617 |
| 2017-06-30 |
$1,468 |
| 2017-03-31 |
$1,391 |
| 2016-12-31 |
$1,558 |
| 2016-09-30 |
$1,498 |
| 2016-06-30 |
$1,507 |
| 2016-03-31 |
$1,435 |
| 2015-12-31 |
$1,547 |
| 2015-09-30 |
$1,487 |
| 2015-06-30 |
$1,465 |
| 2015-03-31 |
$1,473 |
| 2014-12-31 |
$1,820 |
| 2014-09-30 |
$1,789 |
| 2014-06-30 |
$1,849 |
| 2014-03-31 |
$1,824 |
| 2013-12-31 |
$1,793 |
| 2013-09-30 |
$1,714 |
| 2013-06-30 |
$1,583 |
| 2013-03-31 |
$1,496 |
| 2012-12-31 |
$1,464 |
| 2012-09-30 |
$1,825 |
| 2012-06-30 |
$1,779 |
| 2012-03-31 |
$1,654 |
| 2011-12-31 |
$1,759 |
| 2011-09-30 |
$1,707 |
| 2011-06-30 |
$1,655 |
| 2011-03-31 |
$1,484 |
| 2010-12-31 |
$1,444 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$29.390B |
$2.598B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
